Detalles de la búsqueda
1.
ENABLE-SG (Educate, Nurture, Advise, Before Life Ends for Singapore) as a proactive palliative care model: protocol for a hybrid type 1 effectiveness-implementation randomized wait-list controlled trial.
BMC Palliat Care
; 23(1): 29, 2024 Jan 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-38287335
2.
Addressing cellular heterogeneity in tumor and circulation for refined prognostication.
Proc Natl Acad Sci U S A
; 116(36): 17957-17962, 2019 09 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31416912
3.
Concurrent Single-Cell RNA and Targeted DNA Sequencing on an Automated Platform for Comeasurement of Genomic and Transcriptomic Signatures.
Clin Chem
; 65(2): 272-281, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30523199
4.
Effects of Single Nucleotide Polymorphisms on the Binding of Afatinib to EGFR: A Potential Patient Stratification Factor Revealed by Modeling Studies.
J Chem Inf Model
; 59(1): 309-315, 2019 01 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-30481018
5.
Mutational Aberrations Detected in Mucinous Epithelial Ovarian Cancer of Asian Women.
Int J Gynecol Cancer
; 28(3): 428-436, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29465505
6.
Single-cell profiling approaches to probing tumor heterogeneity.
Int J Cancer
; 139(2): 243-55, 2016 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26789729
7.
An ultra-high-throughput spiral microfluidic biochip for the enrichment of circulating tumor cells.
Analyst
; 139(13): 3245-55, 2014 Jul 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-24840240
8.
Comparison of an amplicon-based large panel next generation sequencing (NGS) assay with conventional testing methods for MET and HER2 amplification in lung and breast cancers.
Pathology
; 56(3): 325-333, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38195375
9.
Bioengineered hydrogels enhance ex vivo preservation of patient-derived tumor explants for drug evaluation.
Biomaterials
; 305: 122460, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38246018
10.
Combinatorial Hypofractionated Radiotherapy and Pembrolizumab in Anaplastic Thyroid Cancer.
Eur Thyroid J
; 2024 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38181007
11.
Outcomes and prognostic factors of post-irradiation and de novo sarcomas of the head and neck: a histologically matched case-control study.
Ann Surg Oncol
; 20(9): 3066-75, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-23604715
12.
Real-world clinical practice and outcomes in treating stage III non-small cell lung cancer: KINDLE-Asia subset.
Front Oncol
; 13: 1117348, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37051534
13.
Prevalence and clinico-genomic characteristics of patients with TRK fusion cancer in China.
NPJ Precis Oncol
; 7(1): 75, 2023 Aug 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37567953
14.
Safety, Tolerability, and Antitumor Activity of Zipalertinib Among Patients With Non-Small-Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Exon 20 Insertions.
J Clin Oncol
; 41(26): 4218-4225, 2023 09 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37384848
15.
Clinical efficacy and biomarker analysis of dual PD-1/CTLA-4 blockade in recurrent/metastatic EBV-associated nasopharyngeal carcinoma.
Nat Commun
; 14(1): 2781, 2023 05 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37188668
16.
Real world efficacy of osimertinib in second line/beyond in patients with metastatic EGFR+ non-small cell lung cancer and role of paired tumour-plasma T790M testing at tyrosine kinase inhibitor resistance.
Transl Lung Cancer Res
; 12(4): 742-753, 2023 Apr 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-37197627
17.
Biomarker-directed, pembrolizumab-based combination therapy in non-small cell lung cancer: phase 2 KEYNOTE-495/KeyImPaCT trial interim results.
Nat Med
; 29(7): 1718-1727, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37429923
18.
Inferring cancer disease response from radiology reports using large language models with data augmentation and prompting.
J Am Med Inform Assoc
; 30(10): 1657-1664, 2023 09 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-37451682
19.
Dietary factors and the risk of lung cancer by epidermal growth factor receptor mutation status and histological subtypes.
Front Public Health
; 10: 1079543, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36530673
20.
Real-world global data on targeting epidermal growth factor receptor mutations in stage III non-small-cell lung cancer: the results of the KINDLE study.
Ther Adv Med Oncol
; 14: 17588359221122720, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36119641